These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 2833440)

  • 1. Outer membrane protein F preparation of Pseudomonas aeruginosa as a vaccine against chronic pulmonary infection with heterologous immunotype strains in a rat model.
    Gilleland HE; Gilleland LB; Matthews-Greer JM
    Infect Immun; 1988 May; 56(5):1017-22. PubMed ID: 2833440
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preservation of pulmonary function by an outer membrane protein F vaccine. A study in rats with chronic pulmonary infection caused by Pseudomonas aeruginosa.
    Fox CW; Campbell GD; Anderson WM; Zavecz JH; Gilleland LB; Gilleland HE
    Chest; 1994 May; 105(5):1545-50. PubMed ID: 8181349
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Outer membrane protein F (porin) preparation of Pseudomonas aeruginosa as a protective vaccine against heterologous immunotype strains in a burned mouse model.
    Matthews-Greer JM; Gilleland HE
    J Infect Dis; 1987 Jun; 155(6):1282-91. PubMed ID: 3033095
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vaccine efficacies of elastase, exotoxin A, and outer-membrane protein F in preventing chronic pulmonary infection by Pseudomonas aeruginosa in a rat model.
    Gilleland HE; Gilleland LB; Fowler MR
    J Med Microbiol; 1993 Feb; 38(2):79-86. PubMed ID: 8429543
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A chimeric influenza virus expressing an epitope of outer membrane protein F of Pseudomonas aeruginosa affords protection against challenge with P. aeruginosa in a murine model of chronic pulmonary infection.
    Staczek J; Gilleland HE; Gilleland LB; Harty RN; García-Sastre A; Engelhardt OG; Palese P
    Infect Immun; 1998 Aug; 66(8):3990-4. PubMed ID: 9673294
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chimeric animal and plant viruses expressing epitopes of outer membrane protein F as a combined vaccine against Pseudomonas aeruginosa lung infection.
    Gilleland HE; Gilleland LB; Staczek J; Harty RN; García-Sastre A; Palese P; Brennan FR; Hamilton WD; Bendahmane M; Beachy RN
    FEMS Immunol Med Microbiol; 2000 Apr; 27(4):291-7. PubMed ID: 10727884
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protection against Pseudomonas aeruginosa chronic lung infection in mice by genetic immunization against outer membrane protein F (OprF) of P. aeruginosa.
    Price BM; Galloway DR; Baker NR; Gilleland LB; Staczek J; Gilleland HE
    Infect Immun; 2001 May; 69(5):3510-5. PubMed ID: 11292786
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of a purified outer membrane protein F (porin) preparation of Pseudomonas aeruginosa as a protective vaccine in mice.
    Gilleland HE; Parker MG; Matthews JM; Berg RD
    Infect Immun; 1984 Apr; 44(1):49-54. PubMed ID: 6323316
    [TBL] [Abstract][Full Text] [Related]  

  • 9. DNA vaccines against chronic lung infections by Pseudomonas aeruginosa.
    Staczek J; Gilleland LB; van der Heyde HC; Gilleland HE
    FEMS Immunol Med Microbiol; 2003 Jul; 37(2-3):147-53. PubMed ID: 12832118
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Outer Membrane Vesicles Displaying a Heterologous PcrV-HitA Fusion Antigen Promote Protection against Pulmonary Pseudomonas aeruginosa Infection.
    Li P; Wang X; Sun X; Guan Z; Sun W
    mSphere; 2021 Oct; 6(5):e0069921. PubMed ID: 34612675
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protective effect of an outer membrane vaccine against Pseudomonas aeruginosa infection.
    von Specht BU; Strigl G; Ehret W; Brendel W
    Infection; 1987; 15(5):408-12. PubMed ID: 3121520
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A live-attenuated Pseudomonas aeruginosa vaccine elicits outer membrane protein-specific active and passive protection against corneal infection.
    Zaidi TS; Priebe GP; Pier GB
    Infect Immun; 2006 Feb; 74(2):975-83. PubMed ID: 16428743
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chimeric influenza viruses incorporating epitopes of outer membrane protein F as a vaccine against pulmonary infection with Pseudomonas aeruginosa.
    Gilleland HE; Gilleland LB; Staczek J; Harty RN; Garcia-Sastre A; Engelhardt OG; Palese P
    Behring Inst Mitt; 1997 Feb; (98):291-301. PubMed ID: 9382753
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhancement of the protective efficacy of an oprF DNA vaccine against Pseudomonas aeruginosa.
    Price BM; Barten Legutki J; Galloway DR; von Specht BU; Gilleland LB; Gilleland HE; Staczek J
    FEMS Immunol Med Microbiol; 2002 Jun; 33(2):89-99. PubMed ID: 12052563
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Outer membrane proteins of Pseudomonas aeruginosa as vaccine candidates.
    von Specht B; Knapp B; Hungerer K; Lücking C; Schmitt A; Domdey H
    J Biotechnol; 1996 Jan; 44(1-3):145-53. PubMed ID: 8717398
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunization of burn-patients with a Pseudomonas aeruginosa outer membrane protein vaccine elicits antibodies with protective efficacy.
    Lee NG; Jung SB; Ahn BY; Kim YH; Kim JJ; Kim DK; Kim IS; Yoon SM; Nam SW; Kim HS; Park WJ
    Vaccine; 2000 Mar; 18(18):1952-61. PubMed ID: 10699346
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunological evaluation of OMP-F of native Iranian Pseudomonas aeruginosa as a protective vaccine.
    Ahmadi H; Tabaraie B; Maleknia S; Pormirzagholi F; Nejati M; Hedayati MH
    J Infect Dev Ctries; 2012 Oct; 6(10):721-6. PubMed ID: 23103894
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Post-exposure immunization by capsid-modified AdC7 vector expressing Pseudomonas aeruginosa OprF clears P. aeruginosa respiratory infection.
    Gomi R; Sharma A; Wu W; Sung B; Worgall S
    Vaccine; 2017 Dec; 35(51):7174-7180. PubMed ID: 29126807
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protective immunization against chronic Pseudomonas aeruginosa pulmonary infection in rats.
    Klinger JD; Cash HA; Wood RE; Miler JJ
    Infect Immun; 1983 Mar; 39(3):1377-84. PubMed ID: 6404823
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pseudomonas aeruginosa antigens as potential vaccines.
    Stanislavsky ES; Lam JS
    FEMS Microbiol Rev; 1997 Nov; 21(3):243-77. PubMed ID: 9451816
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.